Table 3.
Molecular profiling of patients with adenosquamous carcinoma of the pancreas: Immunohistochemistry analysis
| IHC analysis percent positive expression (positive/number examined) | ||||||||||||||||||
|
MRP1 |
BCRP |
MGMT |
TOP2A |
TUBB3 |
PTEN |
SPARC |
TOPO1 |
RRM1 |
cMET |
TLE3 |
TS |
ERCC1 |
PGP |
C-kit |
PR |
AR |
ER |
Her2 |
| 80 (8/10) | 80 (4/5) | 76 (16/21) | 78 (14/18) | 38 (3/8) | 41 (9/22) | 39 (9/23) | 38 (8/21) | 43 (9/21) | 33 (4/12) | 42 (5/12) | 38 (8/21) | 31 (4/13) | 11 (2/18) | 10 (1/10) | 5 (1/21) | 0 (0/21) | 5 (1/21) | 0 (0/22) |
IHC: Immunohistochemistry.